Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | SCD | O00767 | 1/20 | 0.30 |
| ▸ | CFTR | P13569 | 2/20 | 0.30 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.30 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.30 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.30 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24984625 | 1.00 | AR (0.33) | ARPOLBSCDCFTRMAPK13 | |
| SCHEMBL24984629 | 1.00 | AR (0.33) | ARPOLBSCDCFTRMAPK13 | |
| SCHEMBL24986295 | 0.95 | TMEM97 (0.31) | — | |
| SCHEMBL24986296 | 0.95 | TMEM97 (0.31) | — | |
| SCHEMBL24986142 | 0.95 | GABRA5 (0.32) | POLBSCDGABRA5 | |
| SCHEMBL24986144 | 0.95 | GABRA5 (0.32) | POLBSCDGABRA5 | |
| SCHEMBL24984624 | 0.94 | SMN1; SMN2 (0.30) | SCD | |
| SCHEMBL24984626 | 0.94 | SMN1; SMN2 (0.30) | SCD | |
| SCHEMBL24985122 | 0.94 | AR (0.34) | ARPOLBMAPK13MAPK12MAPK11 | |
| SCHEMBL24985121 | 0.94 | AR (0.34) | ARPOLBMAPK13MAPK12MAPK11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021198981-A1 | ANTIVIRAL COMPOUNDS AND USES THEREOF | Janssen Biopharma, Inc. (US) | 2021-10-07 | — | — | WO | disclosed |